AndhraNews.net
Home » Features » Companies » GVK Biosciences

GVK Biosciences


GVK Biosciences is an Asian contract research organization (CRO) with 2000 employees. It has five locations in India and is headquartered at Hyderabad. It is stand-alone and integrated services in research and development (R&D). The company provides services for companies in the pharmaceutical, biotechnology industries, including consulting, clinical studies.

GVK Biosciences in News

GVK BIO Signs Definitive Agreement to Acquire Vanta Bioscience
Asia’s leading Discovery Research and Development organization, GVK BIO, announced the signing of a definitive agreement to acquire Vanta Bioscience, a full service preclinical GLP toxicology and safety assessment contract research organization operating out of Chennai, India. Complying with OECD GLP, ISO, USFDA GLP (21 CFR Part 58 rev

GVK BIO Announces Successful Completion of Drug Repurposing Efforts to Identify Novel Indications
GVK Biosciences (GVK BIO) – Asia’s leading integrated Discovery Research and Development organization today announced the successful completion of in-silico based alternative indications of shelved compounds for Takeda Pharmaceutical Company Limited using GVK BIO’s proprietary Drug Repurposing Platform

GVK BIO and Aragen Bioscience Sign Definitive Agreement to Acquire Aragen Bioscience, Inc.
The acquisition of Aragen Bioscience provides GVK BIO with world-class expertise in large molecule R&D services and a unique and extensive set of high-content biological services

GVK BIO and US FDA Announce Drug Repositioning Collaboration - License to GVK BIO SAR Database GOSTAR
GVK Biosciences (GVK BIO) today announced that it has licensed its popular SAR, PK and Toxicity Database (GOSTAR) to the US Food and Drug Administration (USFDA). The Material Transfer Agreement forms the basis of collaboration in Drug Repositioning, wherein the initial focus will be to identify alternative therapeutic indications of marketed compounds for neglected and orphan diseases

Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)
GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators

US FDA Extends License of the GVK BIO Biomarker Database
GVK Biosciences (GVK BIO) today announced that it is extending its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the US Food and Drug Administration (USFDA)

GVK BIO Enters into Research Collaboration with Endo Pharmaceuticals
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development CRO announced today that it has entered into a collaboration agreement with U.S. based Endo Pharmaceuticals focused on discovering novel small molecules targeting an exciting protein

GVK Biosciences and Onconova Therapeutics Establish Novel Joint Development Partnership to Advance New Drugs for Cancer
GVK BIO, Asia’s leading Contract Research and Development organization and Onconova Therapeutics, a U.S. based biopharmaceutical company primarily focused on discovery and development of novel small molecules for Oncology, today announced that they have entered into a novel joint partnership to develop new drugs for Cancer. The joint partnership will be based in the U.S

GVK BIO Establishes the Largest Isotope Labeling Facility in India
GVK Biosciences (GVK BIO) , Asia’s leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities

Inogent Laboratories Clears the Pharmaceuticals and Medical Devices Agency (PMDA), Japan Audit
Inogent Laboratories (Inogent), a GVK BIO associate company announced today that its GMP compliant facilities in Hyderabad were audited and approved by the Japanese regulator, Pharmaceuticals and Medical Devices Agency (PMDA). PMDA conducts scientific reviews of marketing authorization application of pharmaceuticals and medical devices and monitoring of their post-marketing safety

GVK Bioscience’s Ahmedabad Clinical Pharmacology Unit Successfully Clears the USFDA Audit
GVK Biosciences, Asia’s leading Contract Research Organization today announced that its Ahmedabad Clinical Pharmacology Unit successfully cleared the US FDA Audit with zero 483s/observations from the agency. USFDA visited and audited a First-to-File study for one of GVK BIO’s customers. The GVK BIO Ahmedabad facility, commissioned in 2010, has 3 clinics with 110 beds

GVK Biosciences announces Multi-Year Drug Discovery collaboration with the Moulder Center for Drug Discovery Research, Temple University
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization, announced today that it has entered into a drug discovery alliance with the Moulder Center for Drug Discovery Research at Temple University

GVK Biosciences presented the Frost & Sullivan Growth Leadership Award in Contract Research Service Market
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development organization, announced that it was awarded the Frost & Sullivan 2011 Best Practices Award for Growth Leadership in the Contract Research Services Market. The Frost & Sullivan Award for Growth Leadership is presented to the company that has demonstrated excellence in capturing an impressive growth rate

GVK Biosciences Extends the License of its SAR Databases to Astellas Pharma
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization, announced today that Astellas Pharma Inc. (Tokyo:4503, “Astellas”) extended and renewed its license to the GVK BIO SAR Databases (GOSTAR). GOSTAR (GVK BIO Online Structure Activity Relationship (SAR) Database) is an online scientific database product of GVK BIO

GVK Biosciences is the Preferred provider to Global Health Product Development Partners Consortium
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research & development organization announced today that it has been selected as a preferred provider to a consortium of 14 global Product Development Partners (PDPs) for clinical services in Asia. GVK BIO is the only partner that is headquartered in India

INC Research Grows Clinical Trials Services Team in India to Manage Growing Demands in Emerging Region
INC Research, LLC, a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, has recently appointed Shabbir Rangwala, M. as executive director, Global Services and Site Head and Sunil Garg M. senior manager, Clinical Operations to help manage India-based clinical trials, which has been a key region for global drug development efforts

Dow AgroSciences Identifies Lead Molecule in Collaboration with GVK Biosciences
AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today that the company has identified a new lead molecule for advancement in its alliance with GVK Biosciences (GVK BIO), Asia’s leading Contract Research Organization

Fashion And You gets USD 8 Million from Sequoia Capital India
Fashion and You, India’s leading online private sales website today announced that Sequoia Capital has invested USD 8 Million in the company. This investment will go towards growing the company’s product offering, strengthening its enterprise technology, expanding its distribution capacity and funding future growth initiatives. Mr

Comment on this story

Share